Skip to main content
. 2022 Mar 3;17(3):e0264632. doi: 10.1371/journal.pone.0264632

Fig 9. Insulin releasing effects of (A & B) Peak-1 & 2, (C) Quercitrin from BRIN-BD11 cells and, (D & E) glucose tolerance and plasma insulin in mice.

Fig 9

Fasted (12 h) mice were administered glucose (18 mmol /5ml/kg, body weight) orally with or without (D & E) quercitrin (30 mg/5ml/kg b.w.). Values are Mean±SEM for n = 8 for insulin release and n = 7 for glucose tolerance and plasma insulin. *p<0.05, **p<0.01 and ***p<0.001 compared to control.